Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Outperform on American Tower, Lowers Price Target to $228

Author: Benzinga Newsdesk | February 28, 2024 10:26am
BMO Capital analyst Ari Klein maintains American Tower (NYSE:AMT) with a Outperform and lowers the price target from $235 to $228.

Posted In: AMT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist